on 05/12/2007 17:19

BioAlliance Pharma acquires the European commercialization rights to pafuramidine for the treatment of Pneumocystis carinii pneumonia. Building a consistent product portfolio in opportunistic infections in cancer and AIDS patients
Read more

on 29/11/2007 17:00

fluXXion has been selected as one of Technology Pioneers 2008. These 39 visionary companies were nominated by the world's leading technology experts, including venture capitalists, technology companies, academics and media.
Read more

on 28/11/2007 17:15

BioAlliance Pharma accelerates its international clinical research program Extension to the United States of the acyclovir Lauriad® Phase III trial
Read more

on 28/09/2007 13:00

Capricorn Venture Partners announced that it signed up LRM, the regional investment company for Limburg (Belgium) as investor to its Capricorn Cleantech Fund. The Capricorn Cleantech Fund held its first closing in November 2006. Including LRM’s investment of € 10 million, the Fund reached its half-way milestone of € 50 million. The final closing of the Fund, with a target size of € 75 to € 100 million, is foreseen by the end of 2007.
Read more

on 03/08/2007 14:15

Amplexor, a Belgian IT-services company, focusing solely on Enterprise Content Management has implemented a Document Management solution and a Web Content Management system at the Belgian Privacy Commission.
Read more